Investors find it's healthy to diversify in private credit as they back Orbimed fund
Orbimed is targeting a $1.2 billion final close for its latest healthcare royalties fund, underlining the views of Eaton Partners’ Chrystalle Anstett, who said in an interview with Creditflux that investors are looking for assets that are uncorrelated with broader fixed income strategies
Subscriber-only article
This article is available only to Creditflux subscribers and free trial users within 30 days of publication.
Already a subscriber? Not logged in? Click here to login.
If you have not already done so,
you may request a FREE TRIAL by clicking here
This trial will give you:
- 4-weeks' free online access to our
most recent subscriber-only articles - Daily breaking news alert sent by email
- A print copy of Creditflux
If you currently have a free trial, you will see this message when you try to view articles older than 30 days.
Related Stories
- New short-dated CLO brings triple-As down to 132bps 5 hours ago
- Oaktree makes it two new US CLOs this year 5 hours ago
- Symphony refis triple-As from TIAA’s debut CLO 22 hours ago
- Sound Point refinances triple As of 2020 vintage CLO 22 hours ago
- Strong run helps CLOs shrug off Altice downgrade 22 hours ago
Funds
- Allianz gears up to launch European credit impact investing fund 2 days ago
- Schroders Capital adds two senior members to private debt and credit alternatives platform 3 days ago
- Texas pension system commits USD 100m to direct lending 6 days ago
- Pensions specialist Broadstone snaps up credit risk shop 7 days ago
- IACPM survey finds credit PMs still gloomy, but less so than last quarter 7 days ago
